Related Experiment Video
Updated: Oct 11, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H2O2-expressing
Takashi Kitamura1, Hirotaka Nakata1, Daisuke Takahashi1
1Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan. dtak@applc.keio.ac.jp.
Abstract:
A novel tumor-related biomarker, a H2O2-activatable photosensitizer 4 based on the 1,3-dicarbonyl enol moieties of hypocrellin B (3), was designed and synthesized. The photosensitizer 4 showed a blue-shifted absorption band compared with 3, and showed negligible photosensitizing ability without H2O2. However, the release of 3 from 4 by the reaction with H2O2 regenerated the photosensitizing ability. Furthermore, 4 exhibited selective and effective photo-cytotoxicity against high H2O2-expressing cancer cells upon photo-irradiation with 660 nm light, which is inside the phototherapeutic window.
Insights
Researchers developed a novel hydrogen peroxide (H2O2)-activatable photosensitizer. This new compound selectively targets and destroys cancer cells with high H2O2 levels upon light activation, offering a promising photodynamic therapy approach.
Area of Science:
- Medicinal Chemistry
- Photodynamic Therapy
- Biomarker Discovery
Background:
- Hydrogen peroxide (H2O2) is a key biomarker in tumor microenvironments.
- Developing targeted therapies that exploit tumor-specific conditions like elevated H2O2 is crucial.
- Hypocrellin B derivatives offer potential as photosensitizers for photodynamic therapy.
Purpose of the Study:
- To design and synthesize a novel H2O2-activatable photosensitizer.
- To evaluate the photosensitizing ability and H2O2-triggered activation mechanism.
- To assess the selective photo-cytotoxicity against cancer cells with high H2O2 expression.
Main Methods:
- Synthesis of a novel photosensitizer (4) based on hypocrellin B (3) incorporating 1,3-dicarbonyl enol moieties.
- Spectroscopic analysis to compare absorption bands of compounds 3 and 4.
- In vitro evaluation of photosensitizing ability with and without H2O2.
- Assessment of selective photo-cytotoxicity upon irradiation with 660 nm light.
Main Results:
- The novel photosensitizer (4) exhibited a blue-shifted absorption compared to hypocrellin B (3).
- Compound 4 showed minimal photosensitizing activity in the absence of H2O2.
- H2O2 triggered the release of the active photosensitizer (3) from compound 4, restoring photosensitizing ability.
- Compound 4 demonstrated selective and effective photo-cytotoxicity against cancer cells with high H2O2 levels under 660 nm light irradiation.
Conclusions:
- A novel H2O2-activatable photosensitizer was successfully synthesized.
- The photosensitizer exhibits H2O2-dependent activation, releasing the active moiety.
- The compound shows promise for targeted photodynamic therapy in cancer by selectively eliminating high H2O2-expressing cells.
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
